Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Key Financial Ratios
Ajanta Pharma Ltd
    Industry   : Pharmaceuticals - Indian - Formulations  Chairman  : Mannalal B Agrawal
    Home        : Indian Private  Book Value: 266.5059146
    BSE Code  : 532331  Market Cap: 27927.68
    NSE Code  : AJANTPHARM  P / E              : 36.66 

Change Company :
(Rs in Cr.)
Key Finacial Ratios
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.010.010.010.010.00
Long Term Debt-Equity Ratio0.010.010.010.000.00
Current Ratio2.463.032.622.532.61
Fixed Assets1.551.481.351.261.21
Inventory5.174.955.085.174.85
Debtors3.383.443.593.794.14
Interest Cover Ratio134.8199.74131.7468.331252.34
PBIDTM (%)24.3932.8237.5432.4632.91
PBITM (%)20.6728.9633.4428.3128.97
PBDTM (%)24.2432.5337.2832.0532.89
CPM (%)20.1026.7728.9524.2426.04
APATM (%)16.3822.9224.8520.0822.10
ROCE (%)21.6329.6033.4326.6825.04
RONW (%)17.4223.7825.2819.1719.23
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   |   Risk Disclosure   |   Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Attention Investors  
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved    Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified) Content powered by Capital Market